Finally, upon GT treatment, we observed a correction of the expression of the complement receptors CD21 and CD35, which are involved in the capture and presentation of opsonized antigens49 and in negative selection of self-reactive B lymphocytes30 and represent a common trait in patients with WAS.18,27. This evidence concerns the gene CR2 and Wiskott-Aldrich syndrome.